Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Gus
    Member
    • Dec 2009
    • 29

    #1

    State of the field? mapping transcripts to the genome for improving annotation

    I posted this over at Biostars but it has not gotten much response so I am posting it here too.

    I work on Mosquitoes which have notoriously bad annotations in their UTRs. I have a bunch of RNA-seq data that I want to use to help me better define the UTRs in the genes being expressed in my tissues. This is important because I want to study the putative promoter regions. As it is now, MANY regions 5' to the annotated start of the transcript are either UTR or intron due to the gene model missing the first exon (an all UTR exon).

    My plan is to use a few de novo transcript assembly programs to come up with putative cDNA transcripts, then to map these to the genomes to 'annotate' the gene structures and then merge those into the official gtf annotations. For my specific use, the most important things are the border regions (start/stop of transcription), but I plan to publish the amended annotations in an effort to make the work more reproducible. And if they are going to be published, I would like the "guts" to be as accurate with regard to splicing as is reasonably possible.

    I was planning to use exonerate, but in the last few weeks, I have read about other options such as using GMAP or simply using BLAT.

    Is there a feeling of which mapper/method produces the best results at this time?
    In science, "fact" can only mean "confirmed to such a degree that it would be perverse to withhold provisional assent." I suppose that apples might start to rise tomorrow, but the possibility does not merit equal time in physics classrooms.
    --Stephen Jay Gould

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
45 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
34 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
44 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
45 views
0 reactions
Last Post SEQadmin2  
Working...